Headaches - Acetaminophen
Acetaminophen and aspirin have some properties that are alike and others that differ. Acetaminophen, also known as paracetamol, is an analgesic. Aspirin is also an analgesic, pain reliever. Both aspirin and acetaminophen have been used in the treatment of headaches since the 19th century.
Aspirin works by interfering with the action of a type of natural hormone called prostaglandins. These biochemicals come into play during inflammation, such as occurs during injury. Hit your thumb with a hammer and the swelling starts. Prostaglandins stimulate signals through nerve cells that we perceive as pain, and stimulate the swelling. That swelling is the body's reaction to increase blood supply and surround damaged tissue.
But acetaminophen is not an NSAID (Non-Steroidal Anti-Inflammatory Drug) like aspirin or ibuprofen. Consequently, it does not reduce pain from conditions caused by inflammation, as aspirin will. Yet, unlike ibuprofen, it's safe to use during all stages of pregnancy. Ibuprofen is particularly to be avoided in the third trimester.
Acetaminophen has another advantage over aspirin in some cases. In certain diseases, such as Reye's syndrome, acetaminophen can be taken safely. Aspirin is unsafe for those afflicted. It also has many fewer side effects for a wide variety of people.
At proper dosages, acetaminophen doesn't irritate the stomach lining as aspirin can. It also does not carry the same risk of kidney damage as its pharmacological cousin. Aspirin thins the blood, which accounts in part for its use as a heart attack preventative. But clotting can be useful if one is subject to nose bleeds or gets cut. Acetaminophen does not interfere with clotting.
The reasons lie in the similarities and differences between the two closely related compounds. Aspirin interferes with prostaglandin production by inhibiting an enzyme called COX. Though acetaminophens don't reduce those inflammation hormones, it does, paradoxically, inhibit the COX enzymes used to produce them.
On the other hand, there is some risk associated with acetaminophen when taken at improperly high dosages. Daily use can lead to so-called rebound headaches, and at high enough dosages can cause liver damage and even death. Such risks are low, but are increased by, for example, taking it in conjunction with alcohol.
Some more common side effects to watch out for include bloody or black, tarry stools, skin rash and sore throat (not present before beginning treatment). In rare cases, lip ulcers or white spots in the mouth have been reported.
Acetaminophen is a drug and you should always follow the directions and safety instructions. It is usually thought to be safe to take with other over-the-counter pain control medicines. Excedrin for example combines acetaminophen, caffeine, and aspirin. You must always remember to follow label instructions and consult a doctor if you experience a lingering fever or headache.
Red wine, even in moderation, does it for some.
FDA Panel Rejects Black Box Warning On Epilepsy Drugs
A panel of experts that advises the US Food and Drug Administration (FDA) voted last week to reject the Agency's proposal to make manufacturers of 11 epilepsy drugs put the strongest level of warning label on their products (the Black Box warning). The FDA had recommended the Black Box warning because studies showed the drugs had nearly double the risk of suicide compared to placebo, although in absolute terms it was still quite small.
Migraine Linked To Blood Clots In Veins
People with migraines may also be more likely to develop blood clots in their veins, according to a study published in the September 16, 2008, issue of Neurology, the medical journal of the American Academy of Neurology. In the condition, called venous thrombosis or thromboembolism, blood clots form in a vein, which can limit blood flow and cause swelling and pain. Those clots can then dislodge from the vein and travel to the heart and the lungs, which can be fatal.
Oral CGRP Receptor Antagonist Showed Statistically Significant Improvement In Migraine Relief Versus Placebo
Merck Sharp & Dohme Limited announced that in a Phase III clinical trial telcagepant (formerly known as MK-0974) - an investigational oral calcitonin gene-related peptide (CGRP) receptor antagonist - significantly relieved moderate-to-severe migraine attacks, including migraine pain and migraine-associated symptoms, compared to placebo. In addition, the overall rates of adverse events in this trial were similar for telcagepant and placebo.
It is much more desirable to prevent the headache than to treat the resulting pain. That can produce pockets or channels that hold or accumulate fluid - the result can be a form of sinusitis. While this may seem like a difficult choice to make, it is necessary part of maintaining your health. Life-factors, such as moving to a new town, work or relationship stress and others can produce headaches.
|
